ID

22507

Description

Study ID: 100273 Clinical Study ID: HS2100273 Study Title: A Randomized, Double-Blind, Placebo-Controlled, Multicenter 60-Day Study Comparing the Efficacy of Valtrex 1 Gram Once Daily vs. Placebo Once Daily in Reducing Viral Shedding in Immunocompetent Subjects with Recurrent HSV-2 Genital Herpes Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 4 Study Recruitment Status: Completed Generic Name: valaciclovir Trade Name: ZELITREX,Valtrex,RAPIVIR,Novirus Study Indication: Herpes Genitalis Visit description: Study conclusion

Mots-clés

Versions (1)
  1. 06/06/2017 06/06/2017 -
Téléchargé le

6 juin 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Efficacy of Valtrexin in Subjects with Recurrent HSV-2 Genital Herpes Study conclusion

Anglais

Efficacy of Valtrexin in Subjects with Recurrent HSV-2 Genital Herpes Study conclusion

1 Formulaires  
Study Conclusion
Description

Study Conclusion

Alias
UMLS CUI-1
C1707478
Subject Identifier
Description

Subject Identifier

Type de données

text

Alias
UMLS CUI [1]
C2348585
Date of subject completion or withdrawal
Description

Date of subject completion or withdrawal

Type de données

date

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0011008
UMLS CUI [2,1]
C2826674
UMLS CUI [2,2]
C0011008
Was the subject withdrawn from the study?
Description

withdraw

Type de données

text

Alias
UMLS CUI [1]
C2349954
If Yes, check the primary reason for withdrawal:
Description

reason for withdrawal

Type de données

integer

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0392360
Reason for withdrawal: If other, please specify
Description

reason for withdrawal

Type de données

text

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0392360
Retour au début de la page

Similar models

Efficacy of Valtrexin in Subjects with Recurrent HSV-2 Genital Herpes Study conclusion

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Study Conclusion
C1707478 (UMLS CUI-1)
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Date of subject completion or withdrawal
Item
Date of subject completion or withdrawal
date
C2349954 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C2826674 (UMLS CUI [2,1])
C0011008 (UMLS CUI [2,2])
Item
Was the subject withdrawn from the study?
text
C2349954 (UMLS CUI [1])
withdraw
Code List
Was the subject withdrawn from the study?
CL Item
Yes (Y)
CL Item
No (N)
Item
If Yes, check the primary reason for withdrawal:
integer
C2349954 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
reason for withdrawal
Code List
If Yes, check the primary reason for withdrawal:
CL Item
Adverse Event (1)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Other (5)
reason for withdrawal
Item
Reason for withdrawal: If other, please specify
text
C2349954 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial